Update on Idiopathic Intracranial Hypertension Management
Open Access
- 1 May 2022
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 80 (5 suppl 1) , 227-231
Abstract
Background: Idiopathic Intracranial Hypertension (IIH) is a secondary headache with a steadily growing incidence. Currently, there is little evidence to guide the treatment of IIH. Objective: To review the pathophysiology of IIH, with focus on the role of obesity as a risk factor, and the implications for new therapeutic perspectives. Methods: in this narrative review, we summarized the current knowledge on treatment options highlighting available evidence for managing intracranial hypertension, obesity, and headache. Results: Clinical Presentation: headache is the most common symptom and a significant cause of quality-of-life impairment. Visual loss is common in the diagnosis. Pathophysiology: there is no unified theory able to explain all symptoms and the evolution of the disease. There is growing data pointing to metabolic changes and obesity with a central role in IIH pathophysiology. Treatment: most published data on IIH treatment is related to pressure control and protection from visual loss. Acetazolamide and cerebrospinal fluid diversion are the best options available. Optic nerve sheath fenestration might be useful to temporally control the pressure over the optic nerve and thus protect from visual deterioration. Recently, venous sinus stenting has proven to be a safe option in selected cases. Finally, bariatric surgery has proven to effectively control elevated intracranial pressure. Conclusion: IIH is a potential cause of high disability. Early recognition is important, and treatment should be tailored to the needs of each case. There is a lack of research on headache management, which might persist after ICP control.Keywords
This publication has 32 references indexed in Scilit:
- Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and childrenNeurology, 2013
- Optic Nerve Sheath Fenestration vs Cerebrospinal Diversion ProceduresJournal of Neuro-Ophthalmology, 2013
- Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year reviewCephalalgia, 2011
- Weight gain and recurrence in idiopathic intracranial hypertensionNeurology, 2011
- Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts – case series and literature reviewBritish Journal Of Neurosurgery, 2011
- A Comparison of Idiopathic Intracranial Hypertension With and Without PapilledemaHeadache: The Journal of Head and Face Pain, 2009
- Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label studyActa Neurologica Scandinavica, 2007
- Profiles of Obesity, Weight Gain, and Quality of Life in Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)American Journal of Ophthalmology, 2007
- The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)Ophthalmology, 1998
- Assessment of visual function in idiopathic intracranial hypertension: A prospective studyEye, 1998